The Observer in the U.K. is the first mainstream news outlet to cover Boris Pasche and Frederico Costa's cancer therapy that uses weak RF radiation to shrink liver tumors. The story was posted today by Robin McKie with the headline, "Hopes Rise for New Cancer Treatment After Tests with Electromagnetism." McKie includes a cautious assessment from Cancer Research UK, a leading charity and the publisher of the British Journal of Cancer. Pasche reveals that he has a go-ahead from the FDA to embark on large-scale trials —and that he is now looking for financial support. (See our earlier story on Pasche's TheraBionic therapy and "Specific Frequencies Block Growth of Cancer Cells," his most recent paper). January 8… Today, Sunday, the Daily Mail picked up the story from the Observer under the headline, "Hopes of Cancer Breakthrough with Treatment Using Electromagnetic Fields To Shrink Tumours.
Return to Short Takes Archive